Purpose

The study provides six months free medication treatment for depression to compare the effects of two approved antidepressant drugs on suicidality. Patients are assigned to one of the drugs (50/50 chance for either). If the medication is not helpful, it will be changed. There is no placebo.

Type of Study: Clinical Trial
Setting of Study: both
Clinical Trials.gov number: NCT00429169
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Filling Out Forms
Computer Tasks
Blood Samples
Blood Samples for DNA
Psychophysiology measurements

Eligibility

Ages Eligible for Study: 18 Years - 75 Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.

Criteria

Location: New York State Psychiatric Institute Unit 42 1051 Riverside Drive New York, NY 10032
Clinic: Neuroscience Clinic for Mood and Personality Disorders
Division: Neuroscience

Study chairs or principal investigators:
Michael Frederic Grunebaum MD, Principal Investigator

Co-investigators:
J. John Mann,
Maria Oquendo,
Marianne Gorlyn,
Barbara Stanley,